Assessment reveals predictors of shorter survival in older patients with head and neck cancers undergoing treatment, suggesting targeted approaches may improve outcomes.
Among older Indian patients with locally advanced head-and-neck squamous cell carcinoma planned for concurrent chemoradiation, 71.3% patients went on to receive concurrent chemotherapy following the GA. Frailty, vulnerability in nutrition, poor performance status and higher CARG chemotherapy toxicity prediction score were predictive for shorter survival.
No takes yet. Share an insight, caveat, or question.
Noronha et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: